2013 annual financial data
Viridian Therapeutics 2013 Net margin
Direct answer
Net margin was -50.03%.
Operating income was -196,213 USD and net income was -2,159,669 USD.
Operating cash flow was -1,167,793 USD.
Get free Viridian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,316,484 USD
- Operating income
- -196,213 USD
- Net income
- -2,159,669 USD
- Operating cash flow
- -1,167,793 USD
Explore related company data
View all 2013 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Viridian Therapeutics financial years